Gender differences in analgesia for endodontic pain

Area of Science:

• Dentistry
• Pharmacology
• Clinical Trials

Background:

• Postoperative endodontic pain is a common concern for dental patients.
• Effective pain management is crucial for patient comfort and treatment success.
• Understanding sex-based differences in analgesic response is important for personalized pain relief.

Purpose of the Study:

• To evaluate the analgesic efficacy of ibuprofen, pentazocine/naloxone, and placebo for postoperative endodontic pain.
• To investigate potential sex-dependent differences in pain relief between male and female patients.

Main Methods:

• A prospective, randomized, double-blind clinical trial involving 43 dental patients.
• Participants received ibuprofen 600 mg, placebo, or pentazocine 50 mg/0.5 mg naloxone orally every 6 hours for 24 hours.
• Pain intensity was recorded using a 100-mm visual analog scale.

Main Results:

• Ibuprofen 600 mg demonstrated significantly greater analgesia than placebo at 6 and 12 hours post-treatment (P = 0.0014, P = 0.0024).
• Pentazocine/naloxone showed significantly greater analgesia than placebo at 12 hours (P = 0.0084).
• Females in the pentazocine/naloxone group reported significantly greater analgesia compared to males (P = 0.007).

Conclusions:

• Ibuprofen and pentazocine/naloxone are effective in managing postoperative endodontic pain.
• Sex influences the analgesic efficacy of pentazocine/naloxone, with females experiencing superior pain relief.
• Further research into sex-specific pain management strategies in endodontics is warranted.